Webinar series

All healthcare systems today are under pressure to spend their resources wisely and efficiently. Ever more often the concept of 'value-based healthcare' is discussed as an idea to improve resource allocation. Value-based healthcare (VBHC), a broad term that describes efforts to maximise quality of care and health outcomes relative to expenditures, is an important trend with the potential to reshape the healthcare landscape.

The 'Future of Value-Based Healthcare in Ireland’ webinar series – hosted by RCSI's Healthcare Outcomes Research Centre in association with Janssen Sciences Ireland and Novartis Pharmaceuticals Ireland – aims to facilitate discussion and introduce new perspectives on VBHC. It also examines what this looks like in an Irish context and what value-based health arrangements, such as a greater focus on disease prevention, outcomes and patient centricity, mean for the Irish health services.

Watch the video

Chaired by former Health Service Executive (HSE) Director General, Tony O’Brien, the first webinar looked at what Ireland can learn from other European countries about ‘pay for performance’ models of healthcare to support better population health outcomes and improved patient experience, while at the same time making better use of available healthcare resources or possibly lowering the costs of care.

Additional speakers:

  • Dr Panos Kefalas, Director of Access Strategy, Cell and Gene Therapy, Catapult
  • Dr Lesley Tilson, Deputy Head, National Centre for Pharmacoeconomics
  • Shane Gannon, Sector Lead, Pharma and Life Science Consulting, PwC Ireland

Useful resources

Paying for Value Over Volume - Panos Kefalas PDF | 711.7 KB Paying for Value Over Volume - Lesley Tilson PDF | 932 KB Paying for Value Over Volume - Shane Gannon PDF | 654.2 KB

Watch the video

This webinar focuses on how Ireland can improve on the collection and use of good-quality real-world health data in the context of value-based healthcare. Health systems can learn from our collective data to improve the quality, integration, and safety of care, but by comparison with our European peers, Ireland fares poorly in the collection and sharing of quality data on care and treatment. Chaired by Business Post columnist and former Health Service Executive Director General Tony O’Brien, the webinar examines key challenges, such as how to improve availability and use of better data for policy making and service planning, clinical decision-making and patient care, for clinical trials and research and for measuring cost-effectiveness and value for money.

Additional speakers:

  • Dr Aisling O’Leary, National Centre for Pharmacoeconomics & School of Pharmacy, RCSI
  • Dr Conor Teljeur, Chief Scientist, Health Information and Quality Authority
  • Dr Thomas Kelley, CEO, Sprink, UK